Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →In a retrospective two-center cohort of 88 pediatric patients undergoing 320 mIBG examinations, cumulative effective dose was approximately 40% lower with [123I]I-mIBG than with [131I]I-mIBG (123 versus 207 mSv).
The record provides observational evidence of lower estimated radiation exposure with [123I]I-mIBG; it is reasonable but unproven to infer that broader access to this isotope could reduce imaging-related radiation burden during repeated neuroblastoma staging and surveillance, without evidence here of improved clinical outcomes.
In a retrospective analysis of 5,393 outpatient notes from 1,661 pediatric patients with NF1 at two tertiary programs, the study found substantial variation and longitudinal incompleteness in documentation of core NF1 features and developed a standardized clinical lexicon mapped to existing terminology standards.
The evidence supports standardized NF1 terminology as a way to improve EHR phenotyping and data harmonization; it is reasonable but unproven to infer that this could improve surveillance, trial identification, and real-world evidence generation, with no direct evidence here of treatment efficacy or improved patient outcomes.
This systematic review aggregates 959 published pediatric erythema nodosum cases, finding infections—especially bacterial infections and tuberculosis—to be the leading reported triggers, with diagnosis usually clinical and management primarily supportive plus treatment of the underlying cause.
The evidence supports cause-directed evaluation and supportive management of pediatric erythema nodosum; by inference, a structured algorithm might also help clinicians recognize uncommon malignancy-associated cases, but the supplied record provides no oncology-specific frequencies, treatment effects, or validation data.
This report describes two children with suprasellar mixed germ cell tumors who developed symptomatic tumor enlargement despite falling AFP and β-HCG during chemotherapy, with resection demonstrating mature teratoma consistent with intracranial growing teratoma syndrome.
The cases provide clinical and histopathologic evidence that falling tumor markers can coexist with enlarging mature teratoma; they support, but do not establish, the hypothesis that prompt surgical evaluation and selected early resection during clinical or radiologic progression may relieve mass effect and possibly limit morbidity.
In a cohort of 4,348 childhood cancer survivors, subsequent thyroid carcinoma and adenoma were associated with neck radiotherapy and Hodgkin lymphoma, while thyroid carcinoma occurred younger and substantially more often than expected relative to the age-matched national population.
The evidence supports using treatment history—particularly neck radiotherapy and prior Hodgkin lymphoma—to identify survivors at elevated risk for long-term thyroid surveillance; whether a risk-adapted surveillance strategy improves outcomes or reduces harms remains an untested inference.
In 138 adolescent and young adult cancer patients receiving anthracyclines, the FADS2-region variant rs97384 was associated with greater odds of reduced skeletal muscle density at follow-up, with additional regional loci also showing associations.
The study provides observational evidence that FADS2-region variants may help identify anthracycline-treated AYA patients at increased risk of early skeletal muscle loss; it remains an untested inference that genotype-guided surveillance, nutrition, or exercise interventions would prevent muscle loss or improve clinical outcomes.
Integrated institutional, bulk-RNA, and single-cell analyses associated TIGIT expression in pediatric B-ALL with CD8+ T-cell and NK-cell exhaustion-related transcriptional features, suppressed antigen-presentation and interferon pathways, and preliminary disease discrimination.
The evidence supports an association between TIGIT expression and exhaustion-related immune signatures in a subset of pediatric B-ALL; it is reasonable but unproven to hypothesize that TIGIT could serve as a biomarker or therapeutic checkpoint target, pending protein-level, functional, and interventional validation.
This qualitative meta-synthesis of 37 studies identifies disrupted parental identity, protective family adaptation, and unmet practical, communication, informational, and psychosocial needs among cancer patients with parenting concerns.
The synthesis supports the existence of family-level supportive-care needs; it is reasonable—but not tested here—to hypothesize that routine assessment, developmentally tailored parent-child communication support, caregiving assistance, and psychosocial referral could reduce distress and improve family adaptation.
This multicenter retrospective cohort of 130 children with genetically confirmed Noonan syndrome found frequent structural MRI abnormalities, including brain tumors in 12.3% and Chiari I malformation in 10.7%, with some imaging findings associated with neurological manifestations and interval progression documented in a subset.
The evidence supports MRI as a potentially useful assessment tool in selected children with Noonan syndrome; it is reasonable but unproven to hypothesize that risk-adapted imaging surveillance could enable earlier management of tumors or progressive cranio-cervical abnormalities and improve outcomes.
In a single-center prospective cohort of 400 children with Mycoplasma pneumoniae pneumonia treated with azithromycin, elevated serum HMGB3 and PCSK9 were associated with poor 7-day treatment response, with a combined predictive AUC of 0.840.
The evidence supports HMGB3 and PCSK9 as candidate short-term response biomarkers in pediatric M. pneumoniae pneumonia; it is an inference, not demonstrated here, that biomarker-guided monitoring or treatment escalation could improve outcomes, and the record provides no pediatric-oncology therapeutic hypothesis.
In a single-center retrospective cohort of 66 children referred with systemic juvenile idiopathic arthritis, 33 carried TNFRSF1A variants and, after genetic assessment and biologic treatment adjustments, were reported to achieve remission with fewer drug switches among those treated after testing.
The record supports an association between early TNFRSF1A testing and fewer biologic-drug switches in this selected autoinflammatory cohort; it suggests—but does not establish—that genotype-informed selection of IL-1, IL-6, or TNF-directed therapy could improve treatment efficiency, with no evidence presented for a pediatric-cancer application.
In baseline data from 935 adults with decompensated cirrhosis and/or hepatocellular carcinoma in the prospective multicenter PAL LIVER trial, FACT-Hep correlated with PROMIS-29 and captured liver disease-specific quality-of-life impairment associated particularly with decompensation and clinical severity.
The record supports FACT-Hep as a clinically relevant patient-reported measure in adults with advanced liver disease; it can be inferred—but is not tested here—that incorporating it into supportive-care trials or symptom monitoring could help identify burdens such as those associated with ascites or hepatic encephalopathy and guide interventions aimed at improving quality of life.
